type stringclasses 2
values | gt_table stringlengths 116 12.6k | image imagewidth (px) 109 761 |
|---|---|---|
complex | <table><tr><td>Year</td><td>Main Objetive</td><td>Assay Employed</td><td>Reference</td></tr><tr><td colspan="4">In vitro studies</td></tr><tr><td>2014</td><td>Effect of MGN on gamma radiation-induced DNA damage in human lymphocytes and lymphoblastoid cells.</td><td>Comet assay</td><td>[74]</td></tr><tr><td>2012</td><td... | |
simple | <table><tr><td>Age group</td><td>No. negative</td><td>No. positive</td><td>positive (%)</td></tr><tr><td>3 to 10</td><td>201</td><td>11</td><td>5.19</td></tr><tr><td>11 to 15</td><td>346</td><td>11</td><td>3.08</td></tr><tr><td>16 to 20</td><td>702</td><td>21</td><td>2.90</td></tr><tr><td>21 to 30</td><td>1116</td><td>... | |
complex | <table><tr><td rowspan="3"></td><td colspan="2">RMSE</td></tr><tr><td>EKF</td><td>BD-AEKF</td></tr><tr><td>Heading (degree)</td><td>1.0069</td><td>0.3751</td></tr><tr><td>Pitch (degree)</td><td>0.6812</td><td>0.1453</td></tr><tr><td>Roll (degree)</td><td>0.6488</td><td>0.1466</td></tr><tr><td>East position (m)</td><td>... | |
complex | <table><tr><td><i>Ownership</i></td><td><i>n(%)</i></td></tr><tr><td>Household owning nets</td><td>638(95.2)</td></tr><tr><td>Households without nets</td><td>32(4.8)</td></tr><tr><td>Total</td><td>670(100)</td></tr><tr><td><i>No. of bed nets</i></td><td><i>No. of HH(%)</i></td></tr><tr><td>0</td><td>32(4.8)</td></tr><t... | |
simple | <table><tr><td>Rank</td><td>Symptoms</td><td>Rate of patients with the symptom</td><td>Rate of patients with high PeCDF (> 50 pg/g lipids)</td></tr><tr><td>1</td><td>Black comedones (trunk) <+ or severer></td><td>0.0671</td><td>0.6563</td></tr><tr><td>2</td><td>uric acid (high)</td><td>0.1761</td><td>0.6310*</... | |
complex | <table><tr><td rowspan="2">Item</td><td colspan="3">IntraobserverObserver 1</td><td colspan="3">IntraobserverObserver 2</td><td colspan="3">InterobserverOver assessments 1</td></tr><tr><td>ICC</td><td>Agreement (in %) </td><td>95% CI</td><td>ICC</td><td>Agreement (in %)</td><td>95% CI</td><td>ICC</td><td>Agreement (in ... | |
simple | <table><tr><td>Protocol</td><td>Denaturation</td><td>Touchdown annealing cycles</td><td>Additional annealing cycles</td><td>Extension</td><td>Final extension</td></tr><tr><td>GP5+/GP6+</td><td>1 min, 94°C</td><td>-</td><td>2 min, 40°C (40–50 cycles)</td><td>1.5 min, 72°C</td><td>4 min, 72°C</t... | |
simple | <table><tr><td>Characteristic</td><td>HR</td><td>95% CI</td></tr><tr><td>Male sex</td><td>1.39</td><td>1.06–1.81</td></tr><tr><td>Age, per 10-year increment</td><td>1.09</td><td>1.07–1.10</td></tr><tr><td>Smoking</td><td>1.34</td><td>1.03–1.76</td></tr><tr><td>Drinking</td><td>1.03</td><td>0.81–... | |
simple | <table><tr><td>Time (h)</td><td><i>p</i>NO<sub>2</sub>PheDU<sup>a</sup> (mM)</td><td>Conversion (%)</td></tr><tr><td>0</td><td>1.94 ± 0.03</td><td>–</td></tr><tr><td>1</td><td>1.63 ± 0.05</td><td>16</td></tr><tr><td>2</td><td>1.29 ± 0.04</td><td>34</td></tr><tr><td>3</td><td>1.24 ± 0.02</td><t... | |
simple | <table><tr><td></td><td>t0 control</td><td>t0 inoculated</td><td>t1 control</td><td>t1 inoculated</td><td>t2 control</td><td>t2 inoculated</td></tr><tr><td>Resistance to antibiotics and toxic compounds</td><td>80.7</td><td>81.4</td><td>78.9</td><td>78.8</td><td>79.7</td><td>79.8</td></tr><tr><td>–</td><td>9.7</td... | |
complex | <table><tr><td><i>Baseline Characteristics (at time of diagnosis)</i></td><td><i>Mean ± SD or N (%)</i></td></tr><tr><td>Age (Years)</td><td>37.41 ± 10.14</td></tr><tr><td colspan="2"><i>Gender</i></td></tr><tr><td> Male</td><td>14 (66.7%)</td></tr><tr><td> Female</td><td>07 (33.3%)</td></tr><tr><td colspan="... | |
complex | <table><tr><td colspan="2"><i>Variables</i></td><td><i>N</i></td><td><i>%</i></td></tr><tr><td rowspan="2"><i>Gender</i></td><td>Male</td><td>29</td><td>58</td></tr><tr><td>Female</td><td>21</td><td>42</td></tr><tr><td rowspan="2"><i>Educational level</i></td><td>Basic science (pre-clinical) years</td><td>12</td><td>24... | |
complex | <table><tr><td>Characteristics</td><td>Patients (P, <i>n</i>=131)</td><td colspan="3">Spousal caregivers (SC, <i>n</i>=131)</td></tr><tr><td></td><td><i>n</i> (%)</td><td colspan="3"><i>n</i> (%)</td></tr><tr><td>Age (mean± SD), years</td><td>56.6±12.1 (ranging from 25 to 79)</td><td colspan="3">56.0±11.... | |
simple | <table><tr><td>Characteristic</td><td>TeleWii Group (<i>n</i> = 38)</td><td>SIBT group (<i>n</i> = 38)</td><td>Baseline comparison <i>p</i> value</td></tr><tr><td>Age (years) (mean ± SD)</td><td>67.45 (7.18)</td><td>69.84 (9.41)</td><td>0.14</td></tr><tr><td>Gender (number of males/females)</td><td>23/15</td><td>2... | |
complex | <table><tr><td> </td><td colspan="3">Johannesburg<sup>**</sup></td><td colspan="3">Cape town</td><td colspan="3">Rustenburg</td></tr><tr><td> </td><td>Surveys<sup>#</sup></td><td>FGDs<sup>^</sup></td><td>Diaries</td><td>Surveys<sup>#</sup></td><td>FGDs<sup>*</sup></td><td>Diaries</td><td>Surveys<sup>#</sup></td><td>FGD... | |
complex | <table><tr><td rowspan="2">Variables</td><td>Total</td><td>First-year</td><td>Fifth-year</td><td rowspan="2">p<sup>c</sup></td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td></tr><tr><td colspan="5">Sociodemographic</td></tr><tr><td> Age<sup>a</sup></td><td>20.4 (3.0)</td><td>19.0 (2.0)</td><td>23.2 (2.3)</td><td>&... | |
complex | <table><tr><td colspan="2"> </td></tr><tr><td>Severe disability</td><td>Any severe cerebral palsy (child non-ambulant and likely to remain so; GMFCS level 4 or 5), severe developmental delay (standardised score <−3 SD) or blindness.</td></tr><tr><td>Moderate disability</td><td>Moderate cerebral palsy (child no... | |
simple | <table><tr><td>What influences the decision about prenatal examinations?</td><td></td></tr><tr><td><i>n</i> = 302</td><td><i>n (%)</i></td></tr><tr><td>Worry about the health of the baby</td><td>268 (89)</td></tr><tr><td>I want to know as much as possible</td><td>117 (39)</td></tr><tr><td>No reasons to refuse</td><td>8... | |
complex | <table><tr><td></td><td></td><td>Crude ORs<sup>ab</sup></td><td>95% CI<sup>c</sup></td><td><i>p</i>-value</td><td colspan="2">Adjusted ORs<sup>d</sup></td><td colspan="2">95% CI</td><td><i>p</i>-value</td></tr><tr><td>Age</td><td>≥30 years</td><td>(reference)</td><td></td><td></td><td colspan="2">(reference)</td>... | |
simple | <table><tr><td>Vascular smooth muscle cells</td><td>Respiratory epithelial cells</td></tr><tr><td>Viability for different pressures (0, 0.4, 0.8, 1.2, 1.6, 2 bar)</td><td>Viability (0.4 bar)</td></tr><tr><td>Viability for different velocities (10, 30, 55, 75, 95 mL/min)</td><td>Short-term differentiation (pan-cytokerat... | |
simple | <table><tr><td><i>p</i> (FWEcorr)</td><td>T</td><td>Z</td><td>Coordinates x, y, z {mm} max. peak</td><td>Brain area</td></tr><tr><td>0.003843</td><td>7.936576</td><td>4.986516</td><td>18, 36, −8</td><td>Right medial orbitofrontal cortex</td></tr></table> | |
simple | <table><tr><td>Economic interventions</td><td>Definition</td><td>Search terms</td></tr><tr><td>Price Interventions - Taxes and Subsidies</td><td>Interventions that target prices for goods and services paid/received by households or firms</td><td>“tax”, “subsidy”, “subsidized”, “... | |
simple | <table><tr><td>Variables</td><td>Negative AV</td><td>Positive AV</td><td><i>P</i> value</td></tr><tr><td>Failure rate (%)</td><td>36.8</td><td>81.2</td><td>0.016*<sup>,b</sup></td></tr><tr><td>Surgical rate (%)</td><td>21.1</td><td>75.0</td><td>0.002*<sup>,b</sup></td></tr><tr><td>AV at PHV (°/y)</td><td>−9.... | |
simple | <table><tr><td> </td><td>Paucigranulocytic phenotype</td><td>Eosinophilic phenotype</td><td>Neutrophilic phenotype</td><td>Mixed granulocytic phenotype</td></tr><tr><td>Steroid naïve (n = 153)</td><td>65 (42.5%)</td><td>60 (39.2%)</td><td>25 (16.3%)</td><td>3 (2%)</td></tr><tr><td>Steroid-treated (n = 355)</td><t... | |
complex | <table><tr><td rowspan="2" colspan="2">Level of Training</td><td colspan="6">Teaching Method</td></tr><tr><td>M</td><td>C</td><td>A</td><td>E</td><td>SLE</td><td>Total</td></tr><tr><td>Junior</td><td>Count</td><td>24</td><td>29</td><td>4</td><td>2</td><td>7</td><td>66</td></tr><tr><td></td><td>% within TM</td><td>77.4<... | |
simple | <table><tr><td>Sample No.</td><td>HN37</td><td>HN44</td><td>HN48</td></tr><tr><td>RL2</td><td>6a</td><td>9c</td><td>8b</td></tr><tr><td>RL3</td><td>11c</td><td>10b</td><td>9a</td></tr><tr><td>SL2</td><td>9a</td><td>12c</td><td>10b</td></tr><tr><td>SL3</td><td>12a</td><td>13b</td><td>12a</td></tr></table> | |
simple | <table><tr><td></td><td>Frequency</td></tr><tr><td>’NNP’,’DISEASE’,’NNP’</td><td>36</td></tr><tr><td>’NNP’,’NNP’,’DISEASE’,’NNP’</td><td>16</td></tr><tr><td>’NNP’,’DISEASE’,’NNP’,’NNP’</td... | |
complex | <table><tr><td></td><td colspan="2">Women</td><td colspan="2">Men</td><td colspan="2">Denominatorwomen</td><td colspan="2">Denominatormen</td></tr><tr><td></td><td>Per cent</td><td>CI</td><td>Per cent</td><td>CI</td><td>Unwt</td><td>Wt</td><td>Unwt</td><td>Wt</td></tr><tr><td colspan="9">Lifetime diagnoses</td></tr><tr... | |
complex | <table><tr><td>Ergonomic instructions</td><td colspan="10">Health complaints often</td></tr><tr><td></td><td colspan="2">Eyes</td><td colspan="2">Neck, shoulders</td><td colspan="2">Head</td><td colspan="2">Hands, fingers, wrists</td><td colspan="2">Lower back</td></tr><tr><td></td><td>n*</td><td>OR (95%Cl)</td><td>N</... | |
complex | <table><tr><td>Characteristic</td><td>Total</td></tr><tr><td>Patients, N</td><td>448</td></tr><tr><td colspan="2">HAE diagnosis, n (%)</td></tr><tr><td> Type 1</td><td>423 (94.4)</td></tr><tr><td> Type 2</td><td>25 (5.6)</td></tr><tr><td colspan="2">Sex, n (%)</td></tr><tr><td> Female</td><td>263 (58.7)</td></tr><tr><t... | |
simple | <table><tr><td>Client Characteristic</td><td>No. (%)</td></tr><tr><td>Sex</td><td></td></tr><tr><td>Female</td><td>1303 (91)</td></tr><tr><td>Male</td><td>122 (9)</td></tr><tr><td>Age, years</td><td></td></tr><tr><td><15</td><td>75 (5)</td></tr><tr><td>15–18</td><td>786 (55)</td></tr><tr><td>19–20</td><t... | |
complex | <table><tr><td></td><td colspan="2">Age</td><td colspan="2">IOP</td><td colspan="2">Number of Glaucoma Medications</td><td colspan="2">AL</td><td colspan="2">ACD</td><td colspan="2">LT</td><td colspan="2">VCD</td></tr><tr><td></td><td>ρ</td><td><i>P</i> value</td><td>ρ</td><td><i>P</i> value</td><td>ρ</t... | |
simple | <table><tr><td>Phenotype</td><td>Loci</td><td>C/C</td><td>C/R</td><td>R/R</td></tr><tr><td>BMI</td><td><i>ht1</i></td><td>518(22.34 ± 3.70)</td><td>904(22.34 ± 3.62)</td><td>454(22.35 ± 3.59)</td></tr><tr><td></td><td><i>ht2</i></td><td>584(22.39 ± 3.64)</td><td>896(22.35 ± 3.63)</td><td>396(22... | |
simple | <table><tr><td>Terms</td><td>aklB, ada</td><td>aklB, ada, dinJ</td></tr><tr><td>DNA repair (SP-PIR)</td><td>5.1E-28</td><td></td></tr><tr><td>DNA damage (SP-PIR)</td><td>6.2E-28</td><td></td></tr><tr><td>Cellular response to stress (GO)</td><td></td><td>7.5E-23</td></tr><tr><td>DNA repair (GO)</td><td></td><td>1.6E-21<... | |
complex | <table><tr><td rowspan="2"></td><td>≤ 11.6</td><td>> 11.6</td><td></td></tr><tr><td><i>N</i> = 129</td><td><i>N</i> = 135</td><td><i>P</i>-value</td></tr><tr><td>Gender (F/M)</td><td>57/72</td><td>62/73</td><td>0.776</td></tr><tr><td>Age (yr)</td><td>28.4 ± 18.75</td><td>41.2 ± 15.58</td><td>< 0.0... | |
complex | <table><tr><td>Data<sup><i>∗</i></sup></td><td>BJK recipe (<i>n</i> = 42)</td><td>Diclofenac (<i>n</i> = 42)</td><td> <i>P</i>value<sup><i>∗∗</i></sup></td></tr><tr><td>Female, number (%)</td><td>38 (90.5)</td><td>39 (92.9)</td><td>0.693<sup>c</sup></td></tr><tr><td>Age; yrs, mean (SD)</td><td>61.67 (... | |
complex | <table><tr><td rowspan="2">Compounds</td><td colspan="3">III Instar</td><td colspan="3">Pupae</td></tr><tr><td>LC<sub>50</sub></td><td>LC<sub> 90</sub></td><td>Chi **</td><td>LC<sub> 50</sub></td><td>LC<sub> 90</sub></td><td>Chi **</td></tr><tr><td><i>t</i>-anethole</td><td>7.4 (6.5–8.3)</td><td>18.8 (17.4–... | |
complex | <table><tr><td>Genotype</td><td>Cases, n=125 (%)</td><td>Controls, n=200 (%)</td><td>Crude OR (95% CI)</td><td>Adjusteda OR (95% CI)</td></tr><tr><td colspan="5"><i>MDM2</i> SNP309</td></tr><tr><td> TT</td><td>30 (24.0)</td><td>62 (31.0)</td><td>1.00 (reference)</td><td>1.00 (reference)</td></tr><tr><td> TG</td><td>61 ... | |
complex | <table><tr><td>Valence class/Emotion</td><td colspan="3">Europeans</td><td colspan="3">Iranians</td></tr><tr><td></td><td>β</td><td><i>T</i></td><td>Partial <i>r</i></td><td>β</td><td><i>T</i></td><td>Partial <i>r</i></td></tr><tr><td>Negative pictures</td><td></td><td></td><td></td><td></td><td></td><td></td... | |
simple | <table><tr><td>AFL</td><td>AML</td><td>Stack</td><td>Description</td></tr><tr><td>signal S</td><td>-</td><td>(--)</td><td>Definition of a signal S.</td></tr><tr><td>: $S .. ;</td><td>DEF</td><td>(arg --)</td><td>Definition of a handler for signal S. The signal argument is pushed on the top of the data stack.</td></tr><... | |
complex | <table><tr><td> </td><td colspan="2">n</td><td>% who correctly identified the firstline anti-malarial therapy</td><td>Unadjusted odds ratio (95% confidence interval; P value)</td></tr><tr><td>Malaria training</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Attended malaria workshop</td><td> </td><td> </td><td>... | |
complex | <table><tr><td rowspan="2">Link</td><td rowspan="2">Antecedent</td><td rowspan="2">Consequent</td><td rowspan="2">Measure(s) of consequent</td><td colspan="2">results</td></tr><tr><td>Link found?</td><td>Consequent (‘effect’) stronger in DLC?</td></tr><tr><td rowspan="3">A</td><td rowspan="4">DLC training (... | |
simple | <table><tr><td>Characteristics</td><td> </td><td>HAP (n = 94)</td><td> </td><td> </td><td>VAP (n = 117)</td><td> </td></tr><tr><td> </td><td>Adequate treatment n = 43 (%)</td><td>Inadequate treatment n = 51 (%)</td><td>p</td><td>Adequate treatment n = 37 (%)</td><td>Inadequate treatment n = 80 (%)</td><td>p</td></tr><t... | |
simple | <table><tr><td>Characteristic</td><td>cv-lysozyme-3</td><td>cv-lysozyme-1*</td><td>cv-lysozyme-2**</td></tr><tr><td><underline>Lysozyme activity</underline></td><td></td><td></td><td></td></tr><tr><td> Optimal pH</td><td>7.5-8.5</td><td>5.5-6.5</td><td>5.5-6.5</td></tr><tr><td> Optimal ionic strength (I)</td><td>0.005-... | |
complex | <table><tr><td></td><td colspan="3">Utilization of postnatal care</td><td></td></tr><tr><td></td><td></td><td colspan="2">Confidence interval</td><td></td></tr><tr><td>Characteristics</td><td>Odds ratio</td><td>Lower</td><td>Upper</td><td><i>p</i></td></tr><tr><td>Occupation</td><td></td><td></td><td></td><td></td></tr... | |
complex | <table><tr><td></td><td colspan="3">Placebo</td><td colspan="3">TOL ER</td></tr><tr><td></td><td>< 65 years (<i>n</i> = 1171)</td><td>65–74 years (<i>n</i> = 477)</td><td>≥ 75 years (<i>n</i> = 288)</td><td>< 65 years (<i>n</i> = 1360)</td><td>65–74 years (<i>n</i> = 582)</td><td>≥ 75 year... | |
complex | <table><tr><td></td><td></td><td colspan="2"><i>6 MeV</i></td><td colspan="2"><i>9 MeV</i></td><td colspan="2"><i>12 MeV</i></td><td colspan="2"><i>16 MeV</i></td><td colspan="2"><i>20 MeV</i></td></tr><tr><td><i>Cone</i></td><td><i>Depth</i></td><td><i>Measured</i></td><td><i>eMC</i></td><td><i>Measured</i></td><td><i... | |
complex | <table><tr><td> </td><td colspan="2">RIP A (ICMB 841-P3 × 863B-P2)</td><td colspan="2">RIP B (H 77/833-2 × PRLT 2/89-33)</td><td colspan="2">RIP C (81B-P6 × ICMP 451-P8)</td><td colspan="2">RIP D (PT 732B-P2 × P1449-2-P1)</td><td colspan="2">Consensus map</td></tr><tr><td>Linkage groups</td><td>No. ... | |
simple | <table><tr><td>Isolate name</td><td>rpoB<sup>a</sup></td><td>Spoligotype classification</td></tr><tr><td>R160</td><td>Ser531Leu</td><td>LCC</td></tr><tr><td>R376</td><td>Ser531Leu</td><td>Haarlem</td></tr><tr><td>R458</td><td>Ser531Leu</td><td>Unknown/unique</td></tr><tr><td>R486</td><td>Leu533Pro</td><td>Beijing</td><... | |
complex | <table><tr><td rowspan="2">Gene</td><td>Forward primer (3′-5′)</td><td>Product length (bp)</td><td rowspan="2">NCBI Genbank</td><td rowspan="2">Slope</td><td rowspan="2">R<sup>2#</sup></td><td rowspan="2">Efficiency*</td></tr><tr><td>Reverse primer (5′-3′)</td><td> </td></tr><tr><td colspan="7">... | |
complex | <table><tr><td>OTU</td><td>No. of clones</td><td>Phylogenetic class</td><td>Closest cultivated species (% similarity)</td></tr><tr><td colspan="4">Bioreactor for CH<sub>4</sub> production</td></tr><tr><td><i>Archaea</i></td><td></td><td></td><td></td></tr><tr><td> MET-BR-A01</td><td>49</td><td><i>Methanobacteria</i></t... | |
simple | <table><tr><td></td><td>Average (in days)</td><td>Within 1 week (in %)</td><td>Within 1 month (in %)</td><td>Within 3 months (in %)</td></tr><tr><td>All scientific fields</td><td>39</td><td>15</td><td>61</td><td>92</td></tr><tr><td>General</td><td>40</td><td>14</td><td>58</td><td>92</td></tr><tr><td>Natural sciences</t... | |
complex | <table><tr><td></td><td colspan="2">MAP-tau expression</td><td></td></tr><tr><td>Variable</td><td>Low (%) (AQUA score < 462)</td><td>High (%) (AQUA score > 462)</td><td><i>P* </i></td></tr><tr><td>Menopausal status</td><td></td><td></td><td></td></tr><tr><td> Premenopausal</td><td>108 (22.8)</td><td>31 (6.5)</td>... | |
complex | <table><tr><td>Type or gene involved</td><td>Number</td><td>Mean, kb</td><td>Range, kb</td></tr><tr><td colspan="4">Copy number losses : large</td></tr><tr><td> Interstitial deletion</td><td>18</td><td>5,070</td><td>1,048–16,837</td></tr><tr><td> Terminal deletion</td><td>14</td><td>5,273</td><td>1,218–13,5... | |
complex | <table><tr><td colspan="2">Age group of children (months)</td><td colspan="2">Rotavirus status of Children</td><td></td><td></td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td>Total</td><td>P-value</td></tr><tr><td>0-6</td><td>count</td><td>2</td><td>8</td><td>10</td><td></td></tr><tr><td></td><td>% o... | |
complex | <table><tr><td>Dataset</td><td></td><td>#Subjects</td><td>#Case</td><td>Platform</td><td>#SNPs</td></tr><tr><td>Croatia</td><td><i>(Before QC)</i></td><td>306</td><td>103</td><td>Illumina 550 K</td><td>561,466</td></tr><tr><td></td><td><i>(After QC)</i></td><td>305</td><td>103</td><td></td><td>489,200</td></tr><tr><td>... | |
simple | <table><tr><td>Species</td><td>Female</td><td>Male</td></tr><tr><td><i>Dichaetophora acutissima</i></td><td>20</td><td>25</td></tr><tr><td><i>Drosophila annulipes</i></td><td>31</td><td>27</td></tr><tr><td><i>Drosophila bizonata</i></td><td>31</td><td>31</td></tr><tr><td><i>Drosophila busckii</i></td><td>35</td><td>41<... | |
complex | <table><tr><td></td><td colspan="2"><i>Arabidopsis</i></td><td colspan="2">Rice</td></tr><tr><td>Origin of nat-siRNAs</td><td>Total</td><td>Unique</td><td>Total</td><td>Unique</td></tr><tr><td>Entire NATs</td><td>33,826</td><td>17,059</td><td>162,397</td><td>56,209</td></tr><tr><td> Introns in entire NATs</td><td>14,50... | |
simple | <table><tr><td>Sample</td><td>Potential (mV)</td><td>Dissolution Current Density at −400 mV (A cm<sup>−2</sup>)</td></tr><tr><td>No Exposure</td><td>−486.5</td><td>1.3 × 10<sup>−4</sup></td></tr><tr><td>Arica</td><td>−574.7</td><td>4.0 × 10<sup>−4</sup></td></tr><tr><td>Qui... | |
simple | <table><tr><td></td><td></td><td></td><td></td><td></td><td>It is likely that people who</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>have consumed bushmeat in</td></tr><tr><td>Variable</td><td>Response</td><td>Estimatea</td><td>SE</td><td>RVIb</td><td>the year prior to survey...</td></tr><tr><td>ARUc<... | |
simple | <table><tr><td>Gene</td><td>GC% <i>M. davidii</i></td><td>GC% <i>P. alecto</i></td><td>Gene length <i>M. davidii</i></td><td>Gene length <i>P. alecto</i></td></tr><tr><td><i>IKZF1</i></td><td>49.6</td><td>53.2 / 51.5</td><td>1908</td><td>228/816</td></tr><tr><td><i>GPSM1</i></td><td>49.1</td><td>65.4</td><td>705</td><t... | |
complex | <table><tr><td> </td><td> </td><td colspan="2">All subjects (N = 15)</td><td> </td></tr><tr><td> </td><td> </td><td>Completed (N = 10)</td><td>Withdrawn (N = 5)</td><td> </td></tr><tr><td> </td><td>Mean (SD)</td><td> </td><td> </td><td>P</td></tr><tr><td>Age yrs</td><td>67.9 (9.4)</td><td>67.6 (10.9)</td><td>68.4 (6.3)... | |
complex | <table><tr><td rowspan="2" colspan="2">Clinicopathological parameters</td><td rowspan="2"><i>n</i></td><td colspan="2">NgBR expression</td><td rowspan="2"><i>P</i></td></tr><tr><td>Low</td><td>High</td></tr><tr><td colspan="2">Age (y)</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>≤ 54</td><td>47</... | |
complex | <table><tr><td></td><td colspan="3">Parameter</td></tr><tr><td>GROUP</td><td>Norepinephrine</td><td>Dopamine</td><td>Serotonin</td></tr><tr><td>Control</td><td>0.376 ± 0.07</td><td>1.45 ± 0.12</td><td>0.80 ± 0.115</td></tr><tr><td>Leaded gasoline</td><td>0.47 ± 0.086 a*</td><td>1.71 ± 0.14 a*</... | |
simple | <table><tr><td>MIGS ID</td><td>Characteristic</td><td>Details</td></tr><tr><td>MIGS-28</td><td>Libraries used</td><td>2kb (pUC19) and 40kb (pcc1FOS) Sanger and 454 standard libraries</td></tr><tr><td>MIGS-29</td><td>Sequencing platform</td><td>ABI-3730, 454 GS FLX Titanium</td></tr><tr><td>MIGS-31.2</td><td>Sequencing ... | |
simple | <table><tr><td>Criteria</td><td>Percentage</td></tr><tr><td>WHO</td><td>61.43%</td></tr><tr><td>Not sure</td><td>17.14%</td></tr><tr><td>ADA</td><td>12.38%</td></tr><tr><td>IADPS</td><td>9.05%</td></tr></table> | |
complex | <table><tr><td rowspan="2"></td><td colspan="5">Coefficient of drug interaction (CDI)</td></tr><tr><td>Etoposide</td><td>Epirubicin</td><td>Doxorubicin</td><td>Vincristine</td><td>Colchicine</td></tr><tr><td>Ad5GS3</td><td>0.27</td><td>0.31</td><td>0.33</td><td>0.89</td><td>0.78</td></tr><tr><td>Ad5WS1</td><td>0.67</td... | |
complex | <table><tr><td>Exophily</td><td>No. caught</td><td>Exiting % (95% CI)</td><td>Median IQR exiting</td><td>OR</td><td>95% CI</td><td><i>P</i>-value</td><td><i>Z</i></td></tr><tr><td colspan="8">Control net</td></tr><tr><td> West African hut</td><td>587</td><td>35 (31–39)</td><td>2 (0.5–3)</td><td>1</td><td></... | |
complex | <table><tr><td></td><td></td><td>WT</td><td>AS5<sup>ox</sup>-1</td><td>AS5<sup>ox</sup>-2</td></tr><tr><td colspan="2">*Days to Flowering from Planting</td><td>50.60 ± 1.43</td><td>53.80 ± 0.79</td><td>53.80 ± 0.79</td></tr><tr><td colspan="2">*Total Chlorophyll (g/m<sup>2</sup>) at Maturity</td><td>0.75... | |
simple | <table><tr><td>Wired</td><td>Wireless</td></tr><tr><td>High bandwidth</td><td>Low-medium bandwidth</td></tr><tr><td>High performance</td><td>Higher latency</td></tr><tr><td>Robust</td><td>Interference</td></tr><tr><td>Reliable</td><td>Unreliable by nature</td></tr><tr><td>Installation expensive</td><td>Installation che... | |
complex | <table><tr><td rowspan="2">Characteristics</td><td>Total</td><td></td><td colspan="2">Physical activity</td></tr><tr><td>N</td><td>n<sup>d</sup> (%)</td><td>COR(95%CI)</td><td>AOR(95%CI)</td></tr><tr><td>Total</td><td>2063</td><td>2007 (97.3%)</td><td></td><td></td></tr><tr><td colspan="5">Age groups</td></tr><tr><td> ... | |
complex | <table><tr><td></td><td colspan="2">ALT (U/L)</td><td colspan="2">AST (U/L)</td><td colspan="2">Alkaline Phosphatase (U/L)</td><td colspan="2">Total Billirubin (mg/dL)</td></tr><tr><td></td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td><td>HP</td><td>SP</td></tr><tr><td>Baseline</td><td>27.07 ±... | |
complex | <table><tr><td>Dose, Subgroup (n at final visit)</td><td>Physical ComponentSummary</td><td>Mental ComponentSummary</td><td>Mental HealthDomain</td></tr><tr><td colspan="4">Elderly</td></tr><tr><td colspan="4">1 mg, with psychiatric disorders (n = 37)<sup>a</sup></td></tr><tr><td>Baseline</td><td>40.9 (15.9)</td><td>43.... | |
simple | <table><tr><td>Training section</td><td>Examples for tasks</td></tr><tr><td>Planning strategies</td><td>Shopping lists, key search of the BADS subscales, to get items out of a bottle, special wooden 3-dimensional jig saw </td></tr><tr><td>Mnemonics</td><td>Using memory hooks, writing of suitable mnemonics, and planning... | |
simple | <table><tr><td>Gene</td><td></td><td>N</td><td>Mean ± SD</td><td>P-value (Mann-Whitney test)</td></tr><tr><td>APC</td><td>Cases</td><td>11</td><td>2.06 ± 2.6</td><td>0.3</td></tr><tr><td></td><td>Controls</td><td>10</td><td>0.95 ± 1.31</td><td></td></tr><tr><td>ATM</td><td>Cases</td><td>9</td><td>0.5 ... | |
complex | <table><tr><td>25OHD, ng/mL</td><td colspan="2">25OHD ≤ 12</td><td colspan="2">13 < 25OHD ≤ 19</td><td colspan="2">20 < 25OHD ≤ 30</td><td colspan="2">25OHD > 30</td><td></td></tr><tr><td></td><td colspan="2"><i>n</i> = 2</td><td colspan="2"><i>n</i> = 9</td><td colspan="2"><i>n</i> = 15</td>... | |
simple | <table><tr><td>Variable</td><td><i>N</i></td><td> </td></tr><tr><td>Age (yrs)</td><td>51</td><td>66.7 (12.0)</td></tr><tr><td>Sex (M/F)</td><td>51</td><td>26/25</td></tr><tr><td>MMSE</td><td>51</td><td>28.7 (1.4)</td></tr><tr><td>Education</td><td>51</td><td>5 (2)</td></tr><tr><td>NRS 50 kPa </td><td>51</td><td>1.2 (1.... | |
complex | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Blood flow (ml/min)<sup>a</sup></td><td>421 ± 42</td></tr><tr><td>Time of utilization (h)</td><td>30.6 ± 21.0</td></tr><tr><td>Access pressure (mmHg)<sup>a</sup></td><td>− 145 ± 14</td></tr><tr><td>Filter pressure (mmHg)<sup>a</sup></td><... | |
complex | <table><tr><td></td><td><i>N</i></td><td>Dog Owners(<i>n</i> = 43)</td><td>Non dog owners(<i>n</i> = 43)</td></tr><tr><td colspan="4">Match Characteristics</td></tr><tr><td> Gender (<i>N</i> female, %)</td><td>43</td><td>27 (63%)</td><td>27 (63%)</td></tr><tr><td> Age at start of study (years)</td><td>43</td><td>69.9 (... | |
simple | <table><tr><td>FAK location</td><td>Parameter</td><td>Correlation co-efficient</td><td>p-value</td></tr><tr><td>Vessels</td><td>Patient age</td><td>0.096</td><td>0.246</td></tr><tr><td> </td><td>Tumour size</td><td>0.089</td><td>0.28</td></tr><tr><td>Tumour cells</td><td>Patient age</td><td>-0.138</td><td>0.094</td></t... | |
complex | <table><tr><td>Parameters</td><td>DMFT index</td><td><i>H</i></td><td>Found <i>p</i></td><td><i>p</i></td><td>Sig./N. sig.</td></tr><tr><td rowspan="3">Zn concentration, mmol/l (before stimulation)</td><td><1</td><td rowspan="3">2.54</td><td rowspan="3">0.28</td><td rowspan="3">>0.05</td><td rowspan="3">N. sig.</... | |
simple | <table><tr><td>Parameter</td><td>FS (<i>n</i> = 848)</td><td>FGLS (<i>n</i> = 1556)</td><td>Total (<i>n</i> = 2404)</td></tr><tr><td>Gestational age at birth</td><td></td><td></td><td></td></tr><tr><td>< 28 weeks</td><td>2 (0.2)</td><td>1 (0.1)</td><td>3 (0.1)</td></tr><tr><td>28–32 weeks</td><td>3 (0.4)</td><... | |
simple | <table><tr><td>Experimental groups</td><td>n</td><td>DT days, Mean±SE</td><td>GD days, mean</td><td>Inhibition ratio (%)</td><td>CR number</td></tr><tr><td>Control</td><td>8</td><td>4.6±0.5</td><td></td><td>0</td><td>0</td></tr><tr><td>CDDP</td><td>8</td><td>10.6±1.21</td><td>5.5</td><td>33</td><td>0</td... | |
simple | <table><tr><td>Risk</td><td>Kupelian</td><td>D'Amico</td><td>Pound</td></tr><tr><td>Low</td><td>85%</td><td>83%</td><td>94-82%</td></tr><tr><td>Intermediate</td><td>65%</td><td>50%</td><td>72%</td></tr><tr><td>High</td><td>32%</td><td>28%</td><td>54%</td></tr></table> | |
complex | <table><tr><td></td><td colspan="7">Days of pseudopregnancy</td></tr><tr><td>Cell Types</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td></tr><tr><td>Luminal epithelium</td><td>+</td><td>+</td><td>+</td><td>+/-</td><td>+/-</td><td>+/-</td><td>+/-</td></tr><tr><td>Glandular epithelium</td><td>+/... | |
complex | <table><tr><td>Database name</td><td>Organization</td><td>Remarks</td><td>Relevance to investigation interests</td></tr><tr><td>National Health and Nutrition Examination Survey (NHANES)</td><td>CDC</td><td>Section on “Hearing/audiometry (AUQ) for 1 year and over, 1999-2012 with component or lab tests conducted on... | |
complex | <table><tr><td></td><td>Period</td><td colspan="2">Incidence Rate (per 100,000)</td><td colspan="2">Mortality Rate (per 100,000)</td><td colspan="2">Relative Survival Ratio (%)</td></tr><tr><td></td><td></td><td><i>Total</i></td><td><i>Rate (95% CI)</i></td><td><i>Total</i></td><td><i>Rate (95% CI)</i></td><td><i>N*</i... | |
simple | <table><tr><td>Genes</td><td>Forward primer (5′–3′)</td><td>Reverse primer (5′–3′)</td></tr><tr><td>m-PAX2</td><td>AAGCCCGGAGTGATTGGTG</td><td>CAGGCGAACATAGTCGGGTT</td></tr><tr><td>m-WT1</td><td>CAGTTCCCCAACCATTCCTT</td><td>AAGCTGGGAGGTCATTTGGT</td></tr><tr><td>m-Brachyury (Bry)</td>... | |
complex | <table><tr><td></td><td></td><td>N (%) participants</td><td>N (%) valid days</td></tr><tr><td>Full sample</td><td></td><td>23,188 (100%)</td><td>158,784 (100%)</td></tr><tr><td>Sex</td><td>Male</td><td>8819 (38%)</td><td>62,745 (40%)</td></tr><tr><td></td><td>Female</td><td>14,369 (62%)<sup>†</sup></td><td>96,039... | |
complex | <table><tr><td>Locus no.</td><td>Putative identification</td><td>Avg fold difference</td></tr><tr><td colspan="3">Mobile and extrachromosomal element functions: Transposon functions</td></tr><tr><td>PG0019</td><td>ISPg4 transposase</td><td>1.57</td></tr><tr><td>PG0050</td><td>ISPg4, transposase</td><td>1.81</td></tr><t... | |
simple | <table><tr><td>TCGA acronym</td><td>Cancer type</td><td>Paired samples</td><td>Unpaired tumor samples</td><td>Reference</td></tr><tr><td>BRCA</td><td>Breast invasive carcinoma</td><td>107</td><td>929</td><td>(3)</td></tr><tr><td>COAD</td><td>Colon adenocarcinoma</td><td>26</td><td>236</td><td>(1)</td></tr><tr><td>HNSC<... | |
simple | <table><tr><td>Description</td><td>Number of features</td></tr><tr><td>Mean, range, interquartile range (<i>x</i>, <i>y</i>, <i>z</i>)</td><td>9</td></tr><tr><td>Moments: standard deviation, skew, kurtosis (<i>x</i>, <i>y</i>, <i>z</i>)</td><td>9</td></tr><tr><td>Histogram: bin counts of −2 to 1 <i>z</i>-scores (... | |
complex | <table><tr><td rowspan="2">Gene Ontology (GO) Name</td><td rowspan="2">Number of Genes Involve</td><td rowspan="2">Fold Change</td><td colspan="2">Genes</td></tr><tr><td>Highly Expressed in Susceptible Group</td><td>Highly Expressed in Resistant Group</td></tr><tr><td>Negative regulation of transcription from RNA polym... | |
simple | <table><tr><td>Clinicopathological characteristic</td><td>Number (%)</td></tr><tr><td>Age, years</td><td></td></tr><tr><td> Median</td><td>70</td></tr><tr><td> Range</td><td>47–84</td></tr><tr><td>Sex</td><td></td></tr><tr><td> Male</td><td>30 (85.7)</td></tr><tr><td> Female</td><td>5 (14.3)</td></tr><tr><td>Smok... | |
complex | <table><tr><td rowspan="3"></td><td rowspan="3">RNA-Seq datasets comparison</td><td colspan="4">number of DEGs</td></tr><tr><td colspan="2">48 hai</td><td colspan="2">96 hai</td></tr><tr><td>up</td><td>down</td><td>up</td><td>down</td></tr><tr><td rowspan="4">2Hb8</td><td>R NIL <i>Fusarium</i> inoculated – R NIL ... | |
simple | <table><tr><td>Study name</td><td>Treatment arms</td><td>Time horizon (weeks)</td><td>Relapses</td><td>AE-related disc's</td><td>Non-AE-related disc's</td><td>Completers</td><td>Total Nr of patients</td><td>Nr of patients experiencing >7% weight gain (total Nr of patients)</td><td>Nr of patients experiencing EPS (to... | |
simple | <table><tr><td>Compound</td><td>RRI <sup>a</sup></td><td><i>S. boveanum </i></td><td><i>C. myrica</i></td><td><i>H. flagelliformis </i></td></tr><tr><td>Heptadecane</td><td>1698</td><td>-</td><td>-</td><td>4.1 ± 0.63</td></tr><tr><td>Tetradecanoic acid methyl ester</td><td>1718</td><td>8.1 ± 0.7</td><td>20.3 ... | |
simple | <table><tr><td>Traits</td><td>TL</td><td>BL</td><td>BH</td><td>HL</td><td>BW</td></tr><tr><td>TL</td><td>1</td><td></td><td></td><td></td><td></td></tr><tr><td>BL</td><td>0.993</td><td>1</td><td></td><td></td><td></td></tr><tr><td>BH</td><td>0.849</td><td>0.841</td><td>1</td><td></td><td></td></tr><tr><td>HL</td><td>0.... | |
simple | <table><tr><td>Farm location</td><td>Goat breed</td><td>Feed type</td></tr><tr><td>Farm 1 (F1), Hulu Langat, Selangor</td><td>Saanen cross (SC)</td><td>Napier grass silageBarley sproutsDatesMulberry leavesCorn grainGoat pellet</td></tr><tr><td>Farm 2 (F2), Banting, Selangor</td><td>Saanen pure (SP)</td><td>Napier grass... | |
simple | <table><tr><td>Treament</td><td>G0/G1</td><td>S</td><td>G2/M</td><td>Sub G0</td></tr><tr><td>24 Hr Control</td><td>61.6 ± 0.4</td><td>11.6 ± 0.6</td><td>22.5 ± 0.6</td><td>1.5 ± 0.1</td></tr><tr><td>24 Hr Luteolin</td><td>49.3 ± 1.4c</td><td>12.7 ± 1.3</td><td>31.2 ± 0.9b</td><td>3.4 ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.